Boston's Peripheral cutting balloon:
This article was originally published in Clinica
The US FDA has cleared for sale Boston Scientific's Peripheral Cutting Balloon for addressing complications that can occur in patients with end stage renal disease who need haemodialysis. The device is designed to remove blockages in vascular access grafts - soft, synthetic tubes that are used to connect the ends of an artery and vein. It features tiny, longitudinally mounted microsurgical blades on the surface of an angioplasty balloon. As the balloon is expanded, the blades score the lesion with precise incisions. The balloon dilates the vessel at a lower, and more suitable, pressure than traditional angioplasty, the company claimed.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.